Skip to main content

Table 2 Pathological complete response rates relative to patient and tumor characteristics

From: Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

 

pCR (no)

pCR (yes)

n (%) or mean (SD)

n (%) or mean (SD)

Overall

65

56

Age at first diagnosis

51.2 (11.6)

47.3 (10.0)

Age

 < 45 y

20 (50.0)

20 (50.0)

 45–54 y

20 (50.0)

20 (50.0)

 > 54 y

25 (61.0)

16 (39.0)

Tumor size

 ≤ 2 cm

21 (44.7)

26 (55.3)

 > 2 cm

44 (59.5)

30 (40.5)

Grading

 1 or 2

13 (65.0)

7 (35.0)

 3

52 (51.5)

49 (48.5)

Ki-67

 < 36%

19 (70.4)

8 (29.6)

 ≥ 36%

46 (48.9)

48 (51.1)

Chemotherapy

 Anthracycline + taxane

32 (58.2)

23 (41.8)

 Platinum + taxane

33 (50.0)

33 (50.0)

  1. pCR pathologic complete response, SD standard deviation